ATE457353T1 - Virales latentphasen-interleukin-10-(vii-10) und verwendungen davon - Google Patents

Virales latentphasen-interleukin-10-(vii-10) und verwendungen davon

Info

Publication number
ATE457353T1
ATE457353T1 AT04797116T AT04797116T ATE457353T1 AT E457353 T1 ATE457353 T1 AT E457353T1 AT 04797116 T AT04797116 T AT 04797116T AT 04797116 T AT04797116 T AT 04797116T AT E457353 T1 ATE457353 T1 AT E457353T1
Authority
AT
Austria
Prior art keywords
virus
interleukin
latent phase
vii
homologue
Prior art date
Application number
AT04797116T
Other languages
English (en)
Inventor
Barry Slobedman
Allison Abendroth
Christina Jenkins
Original Assignee
Univ Sydney
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2003906613A external-priority patent/AU2003906613A0/en
Application filed by Univ Sydney filed Critical Univ Sydney
Application granted granted Critical
Publication of ATE457353T1 publication Critical patent/ATE457353T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5428—IL-10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Transplantation (AREA)
  • Biotechnology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT04797116T 2003-11-28 2004-11-26 Virales latentphasen-interleukin-10-(vii-10) und verwendungen davon ATE457353T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2003906613A AU2003906613A0 (en) 2003-11-28 Interleukin-10 Homologue and Uses Thereof
PCT/AU2004/001675 WO2005052159A1 (en) 2003-11-28 2004-11-26 Latent phase viral interleukin-10-(vii-10) and uses thereof

Publications (1)

Publication Number Publication Date
ATE457353T1 true ATE457353T1 (de) 2010-02-15

Family

ID=34624267

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04797116T ATE457353T1 (de) 2003-11-28 2004-11-26 Virales latentphasen-interleukin-10-(vii-10) und verwendungen davon

Country Status (6)

Country Link
US (2) US8133700B2 (de)
EP (1) EP1702068B1 (de)
AT (1) ATE457353T1 (de)
AU (1) AU2004293499B2 (de)
DE (1) DE602004025509D1 (de)
WO (1) WO2005052159A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2367891T3 (es) 2000-09-29 2011-11-10 Schering Corporation Interleucina-10 pegilada.
EP3348281B1 (de) 2008-12-17 2023-07-05 Merck Sharp & Dohme Corp. Herstellung von mono- und di-peg il-10 und verwendungszwecke
JP2016519108A (ja) 2013-04-18 2016-06-30 アルモ・バイオサイエンシーズ・インコーポレイテッド インターロイキン−１０を疾病及び疾患の治療に用いる方法
WO2014204816A2 (en) 2013-06-17 2014-12-24 Armo Biosciences, Inc. Method for assessing protein identity and stability
US10010588B2 (en) 2013-08-30 2018-07-03 Armo Biosciences, Inc. Methods of using pegylated interleukin-10 for treating hyperlipidemia
AU2014344807A1 (en) * 2013-10-29 2016-05-19 The University Of Sydney CMV immuno-stimulatory composition
KR20160079114A (ko) 2013-11-11 2016-07-05 아르모 바이오사이언시스 인코포레이티드 질환 및 장애를 치료하기 위한 인터류킨-10을 사용하는 방법
WO2015187295A2 (en) 2014-06-02 2015-12-10 Armo Biosciences, Inc. Methods of lowering serum cholesterol
JP2017536098A (ja) 2014-10-14 2017-12-07 アルモ・バイオサイエンシーズ・インコーポレイテッド インターロイキン−１５組成物及びその使用
WO2016064817A1 (en) 2014-10-22 2016-04-28 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
US10618970B2 (en) 2015-02-03 2020-04-14 Armo Biosciences, Inc. Method of treating cancer with IL-10 and antibodies that induce ADCC
WO2016168741A2 (en) * 2015-04-16 2016-10-20 Spencer Juliet V Detection of human cytomegalovirus
AU2016268403A1 (en) 2015-05-28 2017-12-07 Armo Biosciences, Inc. Pegylated interleukin-10 for use in treating cancer
JP7053453B2 (ja) 2015-08-25 2022-04-12 アルモ・バイオサイエンシーズ・インコーポレイテッド 疾患及び障害を治療するためのインターロイキン１０の使用方法
CN114349858B (zh) * 2022-01-26 2022-07-01 优睿赛思(武汉)生物科技有限公司 抗人白介素-10高亲和力兔单克隆抗体及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001016153A1 (en) 1999-09-02 2001-03-08 University Of Medicine And Dentistry Of New Jersey Cytomegalovirus-encoded il-10 homolog
US6692954B1 (en) 2000-11-03 2004-02-17 The Scripps Research Institute Generation of human cytomegalovirus yeast artificial chromosome recombinants
US7105333B2 (en) 2001-03-27 2006-09-12 Deadreon Corporation Nucleic acid molecules encoding a transmembrane serine protease 9, the encoded polypeptides and methods based thereon
US7361460B2 (en) * 2003-04-11 2008-04-22 Digene Corporation Approach to molecular diagnosis of human papillomavirus-related diseases
US7407744B2 (en) * 2003-07-25 2008-08-05 The Regents Of The University Of California Cytomegalovirus gene function and methods for developing antivirals, anti-CMV vaccines, and CMV-based vectors

Also Published As

Publication number Publication date
EP1702068A4 (de) 2007-07-11
US20120134957A1 (en) 2012-05-31
WO2005052159A1 (en) 2005-06-09
EP1702068A1 (de) 2006-09-20
US20090214463A1 (en) 2009-08-27
AU2004293499A1 (en) 2005-06-09
DE602004025509D1 (de) 2010-03-25
EP1702068B1 (de) 2010-02-10
WO2005052159A8 (en) 2005-08-18
AU2004293499B2 (en) 2009-11-26
US8133700B2 (en) 2012-03-13

Similar Documents

Publication Publication Date Title
ATE457353T1 (de) Virales latentphasen-interleukin-10-(vii-10) und verwendungen davon
ATE376559T1 (de) Methoden der verhinderung und behandlung der alzheimer'schen krankheit
DE60128916D1 (de) Neues, physiologisch aktives peptid und dessen verwendung
DE69536039D1 (de) Wirtszelle enthaltend ein rekombinantes Virus, welches ein Antigen exprimiert und ein rekombinantes Virus, welches ein immunstimulatorisches Molekül exprimiert
BRPI0411363A (pt) seqüências de ácidos nucléicos codificando e composições compreendendo peptìdeo sinal ige e/ou il-15 e processos para uso das mesmas
WO2004085633A8 (en) A novel human virus causing severe acute respiratory syndrome (sars) and uses thereof
NO20052956D0 (no) Defensinprotiner
DK1007685T3 (da) Overfladeeksponerede proteiner fra chlamydia pneumoniae
EA200501711A1 (ru) Семейство секретируемых белков
ATE397624T1 (de) Cystine-knot fold protein
NO20054900L (no) Sekrert proteinfamilie
DE69735039D1 (de) Acetylhydrolase des Plättchen aktivierenden Faktors, und entsprechendes Gen
ATE328080T1 (de) Proteine und für diese kodierende dna
ATE411812T1 (de) Peptide zur behandlung von infektionen mit dem herpes-virus
IL169256A (en) Polypeptide having metalloprotease activity, nucleic acid encoding it and pharmaceutical composition comprising it
HUP0302416A2 (hu) Tisztított hepatitis-C vírusmembrán-proteinek diagnosztikai és terápiás célú alkalmazása
DE69824001D1 (de) Reagenz zum nachweis und weiterverfolgen von virusinfektionen
DE60124523D1 (de) Zusammensetzung einer Parvovirus VP1-Proteinvariante und eines arvovirus NS1-Proteins zur Induktion von Zytolyse
NO20053512L (no) IL-8-liknende proteiner
De Recent Discovery of Peptidomimetics for the Treatment of Coronavirus (COVID-19), Human Coronavirus, and Enteroviruses
CN1258538C (zh) 一种重组蛋白
BR9608837A (pt) "composição obtida de células para detectar uma infecção por vìrus da imunodeficiência humana, aparelho, kit e métodos para sua detecção, purificação da proteìna e sua obtenção e tratamento do ser humano"
IL118103A (en) Composition of thymus factor protein comprising a lysine-rich histone factor capable of precipitating beta-, alpha1-, alpha2-macroglobulins of a healthy mammal
WO2004000882A3 (en) Proteins
DK1556488T3 (da) Human chondroosteomodulin (TIG2), fremstilling og anvendelse heraf til behandling eller diagnose af knoglesygdomme, brusksygdomme, fedme samt inflammatoriske sygdomme og hudsygdomme

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties